Filing Details
- Accession Number:
- 0001493152-20-000240
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-01-06 17:00:14
- Reporting Period:
- 2020-01-02
- Accepted Time:
- 2020-01-06 17:00:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1642380 | Oncocyte Corp | OCX | Biological Products, (No Disgnostic Substances) (2836) | CA |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 876343 | Lineage Cell Therapeutics, Inc. | 2173 Salk Avenue, Suite 200 Carlsbad CA 92008 | No | No | No | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, No Par Value | Disposition | 2020-01-02 | 2,383,090 | $2.16 | 6,041,154 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Billionaire Hedge Funds
